AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Roth IRA vs Traditional IRA for Beginners: Why Choose explains two popular retirement accounts and helps you decide which fits your goals. Learn the core differences and practical steps to start.
26,594 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
A leading bank projects XRP could reach $28 by 2030, even as Ripple pushes a new stablecoin. The forecast highlights ...
In 2026, AMD has taken the lead in the chip market while Nvidia hasn’t kept pace. This piece breaks down why, what co...
Cramer confronted his past mega-cap bets on Mad Money, pivoting to a bullish view on Corning as supplier demand remai...
In 2026, investors face a classic showdown: a rapid-growth dermatology
Amazon is moving deeper into custom AI chips, challenging Nvidia’s data-center dominance. This guide explains how ama...
Hedge funds selling tech has stretched into a fourth straight week, led by semiconductors, as investors weigh the sta...
Micron’s blowout quarter ignited a rally that dwarfed many peers, but the broader memory-chip sector lifted a key ETF...
Dell Technologies surged 248% from year-end 2025 to midsummer 2026, sparking a parallel rally in the IGPT AI ETF. Thi...
Box and DocuSign sit at different corners of the SaaS world. This analysis shows how quarterly revenue patterns illum...
A veteran professional loses footing as AI reshapes his field. Two years later, he weighs claiming Social Security at...
Pentair faced a sharp drop as investors weighed leadership changes, lower guidance, and new scrutiny. This in-depth l...